pwshub.com

Is This Vanguard ETF a Millionaire Maker?

There are many possible ways to become a millionaire. One of the best is simply investing in stocks -- for the long term.

However, you don't want to choose just any stock or buy a stock when it's overvalued. That can leave many of us scratching our heads as to what we should do.

Enter the Vanguard S&P 500 ETF (NYSEMKT: VOO) -- a simple S&P 500 index fund that can make you a millionaire.

Someone is smiling and laughing at the camera.

Image source: Getty Images.

Here's some information on what this ETF is and what it might do for you.

First, the Vanguard S&P 500 ETF is an exchange-traded fund (ETF) -- a fund that trades like a stock. It's also an index fund, aiming to deliver the same performance (less its puny fees) as the S&P 500 index of 500 of America's biggest companies. Its "expense ratio," or annual fee, is just 0.03% -- costing you $3 per year for every $10,000 you have in the fund.

How has this ETF performed in the past? Check out the table below -- but remember that past results don't guarantee future results. (Also, any low-fee S&P 500 index fund, such as those from Fidelity, Schwab, or other good financial companies, will have similar results.)

Period

Average Annual Gain

Past 3 years

11.02%

Past 5 years

16.26%

Past 10 years

14.04%

Past 15 years

13.95%*

Source: Morningstar.com, as of October 21, 2024. Chart by author. 
*Since the Vanguard ETF hasn't been around for 15 years -- its inception date was Sept.7, 2010 -- this figure is from the SPDR S&P 500 ETF (NYSEMKT: SPY).

Here are the Vanguard S&P 500 ETF's top holdings, as of the end of September -- and they will be the same for just about any other S&P 500 index fund, as well:

Stock

Percent of ETF

Apple

7.25%

Microsoft

6.55%

Nvidia

6.11%

Amazon.com

3.56%

Meta Platforms

2.56%

Alphabet Class A

1.99%

Berkshire Hathaway Class B

1.73%

Alphabet Class C

1.64%

Broadcom

1.64%

Tesla

1.49%

Source: Vanguard.com. As of September 30, 2024. Chart by author.

If you're an admirer of the "Magnificent Seven" stocks, due to their impressive performances over many years, you may be happy to know that all seven -- Apple, Microsoft, Google parent Alphabet, Amazon.com, Nvidia, Facebook parent Meta Platforms, and Tesla -- are in the Vanguard S&P 500 ETF. If you buy shares of the index fund, you'll have positions in all seven -- plus 493 other big companies.

How, exactly, might the Vanguard S&P 500 ETF grow your wealth to $1 million (or beyond)? Let's crunch some numbers. And despite those delightful average annual returns in the table above that range from about 11% to 16%, let's be more conservative.

Source: finance.yahoo.com

Related stories
1 week ago - Each ETF quickly invests you in a wide range of dividend-paying stocks -- and dividends are powerful wealth builders.
1 month ago - Artificial intelligence is a booming business these days, with no sign of stopping.
3 weeks ago - Research has shown that dividend stocks become attractive in a rate-cut environment as investors flock to these equities for defensive and offensive portfolios. Data from Ned Davis Research says dividend stocks have historically...
1 month ago - The Federal Reserve's 50bps rate cut has spooked many, as most Wall Street analysts were not expecting an aggressive policy easing from the central bank. Investors are now questioning the true state of the economy and weighing the...
1 month ago - Warren Buffett has wowed us all for quite some time with his smart stock picks and market-beating portfolio. As chairman, he's led Berkshire...
Other stories
20 minutes ago - Investors would probably love to hear a more decisive view. But predicting long-term returns is hard, and these kinds of imprecise assessments are the best we can do as we manage our expectations.
20 minutes ago - Want to add reliable dividend payers to your portfolio? These household names can deliver inflation-beating payouts for many years to come.
1 hour ago - Plans to shut down a vital terminal in the North Sea have sparked a bitter legal row over claims it will damage the UK’s oil and gas production.
2 hours ago - Oklo's stock has surged as investors look to nuclear energy stocks as the next big AI trade. But the company and its competitors face several regulatory and supply-chain hurdles.
3 hours ago - Novo Nordisk dominates diabetes treatment and obesity care, but one clinical-stage pharma company could be the next breakout star.